- Home
- CUE vs FLNT Comparison
CUE vs FLNT Comparison
Compare CUE & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- FLNT
- Stock Information
- Founded
- CUE 2014
- FLNT 2001
- Country
- CUE United States
- FLNT United States
- Employees
- CUE N/A
- FLNT N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- FLNT Advertising
- Sector
- CUE Health Care
- FLNT Consumer Discretionary
- Exchange
- CUE Nasdaq
- FLNT Nasdaq
- Market Cap
- CUE 59.5M
- FLNT 53.4M
- IPO Year
- CUE 2018
- FLNT N/A
- Fundamental
- Price
- CUE $0.74
- FLNT $2.02
- Analyst Decision
- CUE Strong Buy
- FLNT Hold
- Analyst Count
- CUE 2
- FLNT 1
- Target Price
- CUE $3.00
- FLNT $3.00
- AVG Volume (30 Days)
- CUE 116.9K
- FLNT 2.1M
- Earning Date
- CUE 08-12-2025
- FLNT 08-19-2025
- Dividend Yield
- CUE N/A
- FLNT N/A
- EPS Growth
- CUE N/A
- FLNT N/A
- EPS
- CUE N/A
- FLNT N/A
- Revenue
- CUE $8,286,000.00
- FLNT $229,839,000.00
- Revenue This Year
- CUE N/A
- FLNT N/A
- Revenue Next Year
- CUE $10.19
- FLNT $2.01
- P/E Ratio
- CUE N/A
- FLNT N/A
- Revenue Growth
- CUE N/A
- FLNT N/A
- 52 Week Low
- CUE $0.45
- FLNT $1.50
- 52 Week High
- CUE $1.99
- FLNT $3.83
- Technical
- Relative Strength Index (RSI)
- CUE 38.09
- FLNT 44.99
- Support Level
- CUE $0.77
- FLNT $1.88
- Resistance Level
- CUE $0.79
- FLNT $2.22
- Average True Range (ATR)
- CUE 0.04
- FLNT 0.25
- MACD
- CUE -0.01
- FLNT -0.03
- Stochastic Oscillator
- CUE 12.87
- FLNT 16.51
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.